[EEG and clinical psychophysiological study of functional changes in the chronic ischemic brain with increased acetylcholinergic activity].
Sorokina
N D
ND
Selitskiĭ
G V
GV
Kositsyn
N S
NS
D000109:Acetylcholine / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000368:Aged; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D002545:Brain Ischemia / Q000150:complications / Q000378:metabolism / Q000503:physiopathology / Q000523:psychology*; D002908:Chronic Disease; D003071:Cognition / Q000187:drug effects / Q000502:physiology; D015140:Dementia, Vascular / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000523:psychology*; D004569:Electroencephalography; D005260:Female; D005702:Galantamine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D011603:Psychophysiology; D016896:Treatment Outcome
D018697:Nootropic Agents; D005702:Galantamine; D000109:Acetylcholine